American Portfolios Advisors Biomerica Inc Transaction History

American Portfolios Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 22, 2023	BUY	$3.41 - $5.9 $3,410 - $5,900	1,000 New	1,000 $4.01 Million
Q1 2021 Mar 22, 2023	BUY	$5.06 - $8.0 $5,060 - $8,000	1,000 New	1,000 $5.46 Million
Q4 2020 Mar 22, 2023	BUY	$4.71 - $7.85 $4,710 - $7,850	1,000 New	1,000 $4.98 Million
Q3 2020 Mar 22, 2023	BUY	$5.86 - $12.04 $5,860 - $12,040	1,000 New	1,000 $6.93 Million
Q1 2020 Mar 24, 2023	BUY	$2.37 - $16.0 $2,370 - $16,000	1,000 New	1,000 $7.15 Million
Q4 2019 Mar 24, 2023	BUY	$2.67 - $3.3 $2,670 - $3,300	1,000 New	1,000 $3.02 Million
Q2 2019 Mar 24, 2023	BUY	$2.19 - $2.7 $2,190 - $2,700	1,000 New	1,000 $2.6 Million
Q3 2018 Mar 24, 2023	BUY	$3.35 - $4.14 $3,350 - $4,140	1,000 New	1,000 $3.58 Million
Q1 2018 Mar 24, 2023	BUY	$3.81 - $5.3 $3,810 - $5,300	1,000 New	1,000 $4.04 Million
Q4 2017 Mar 24, 2023	BUY	$2.72 - $4.43 $2,720 - $4,430	1,000	1,000 $3.74 Million

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $3.76M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.